-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: January 2012
IPO Update – Jan 2012
2011 ended quietly for the US biotech IPO market. It has now been almost two months without a biotech IPO. The last few IPOs back in November continued the theme that was in place at the beginning of the year – you can get out, but with a -30% haircut. In fact, only two of the 12 IPOs in 2011 raised more than they filed for. This is shown in chart 1 below. The two Read More >
Illinois Sees Biotech as Key to Job Growth
For every job created in the biotech industry, up to five additional jobs are created to build research facilities; maintain laboratory and computer equipment; supply laboratory and office equipment, and provide basic services to even the most modest biotechnology facilities. David Miller of the Illinois Biotechnology Industry Organization is well aware of the above statistic. He shared his views on the challenges and payoffs tied to establishing Chicago as a high-tech employment hub earlier this Read More >
HIV/AIDS and Biotechnology
By David Welch, President/Senior Producer at M2 MultiMedia When the HIV/AIDS epidemic became widely known in the early 1980s I lived in San Francisco. I lost many dear friends during those years. That made working on “HIV/AIDS and Biotechnology” very personal to me. Thirty years later and despite an all-too-common public perception that this terrible disease has been solved, the research to find a vaccine is actually more important than ever. The sad truth is that Read More >
The Future of the Bioscience on Display in Arizona
In this increasingly global economy, science education programs in America are the vital pipeline for developing the bioscience workforce of the future. Sadly, only 52 percent of 12th graders are at or above a basic level of achievement in the sciences, and for 8th graders only 57 percent are at a basic level of achievement. This is why BIO is such a strong advocate of programs that encourage and support students who have an interest Read More >
Virginia Governor McDonnell Aims to Lure Biotech Jobs
Virginia Gov. Bob McDonnell unveiled an economic development package Wednesday that includes $37 million to lure businesses and jobs to the commonwealth. Nearly one quarter of which is earmarked for life sciences and biotechnology industry development — sectors that are staples of the economy of neighboring Maryland. The announcement was made during a press conference, in which Virginia Lt. Gov. Bill Bolling said “There, frankly, are a lot of states around the country over the Read More >
